Closed tender · Czechia · Immunosuppressive agents

Vedolizumab II

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha in Czechia invited bids for “Vedolizumab II”. Bids closed on 9 October 2026, 10:00 CEST; the estimated value is CZK 35.62 million.

Key facts

Estimated value
CZK 35.62 million
Procedure
Contract notice

Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences